ATE492536T1 - Fluorsubstituierte 2-oxo-azepan-derivate - Google Patents

Fluorsubstituierte 2-oxo-azepan-derivate

Info

Publication number
ATE492536T1
ATE492536T1 AT06792637T AT06792637T ATE492536T1 AT E492536 T1 ATE492536 T1 AT E492536T1 AT 06792637 T AT06792637 T AT 06792637T AT 06792637 T AT06792637 T AT 06792637T AT E492536 T1 ATE492536 T1 AT E492536T1
Authority
AT
Austria
Prior art keywords
fluorous
oxo
substituted
azepane derivatives
azepane
Prior art date
Application number
AT06792637T
Other languages
English (en)
Inventor
Alexander Flohr
Guido Galley
Roland Jakob-Roetne
Eric Argirios Kitas
Wolfgang Wostl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE492536T1 publication Critical patent/ATE492536T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06792637T 2005-08-12 2006-08-02 Fluorsubstituierte 2-oxo-azepan-derivate ATE492536T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05107455 2005-08-12
PCT/EP2006/064935 WO2007020190A1 (en) 2005-08-12 2006-08-02 Fluoro substituted 2-oxo azepan derivatives

Publications (1)

Publication Number Publication Date
ATE492536T1 true ATE492536T1 (de) 2011-01-15

Family

ID=37102441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06792637T ATE492536T1 (de) 2005-08-12 2006-08-02 Fluorsubstituierte 2-oxo-azepan-derivate

Country Status (19)

Country Link
US (1) US7501406B2 (de)
EP (1) EP1915345B1 (de)
JP (1) JP4885958B2 (de)
KR (1) KR101020397B1 (de)
CN (1) CN101238106B (de)
AR (1) AR055370A1 (de)
AT (1) ATE492536T1 (de)
AU (1) AU2006281493A1 (de)
BR (1) BRPI0614566A2 (de)
CA (1) CA2619223A1 (de)
DE (1) DE602006019103D1 (de)
ES (1) ES2355581T3 (de)
IL (1) IL189026A0 (de)
MX (1) MX2008001833A (de)
NO (1) NO20080498L (de)
RU (1) RU2419611C2 (de)
TW (1) TWI325421B (de)
WO (1) WO2007020190A1 (de)
ZA (1) ZA200800930B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010509235A (ja) * 2006-11-03 2010-03-25 ノースウェスタン ユニバーシティ 多発性硬化症の治療
FR2913886B1 (fr) 2007-03-22 2012-03-02 Guerbet Sa Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer
GB201009603D0 (en) 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent
WO2012014127A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited 5-lipoxygenase inhibitors
AR097279A1 (es) 2013-08-09 2016-03-02 Actelion Pharmaceuticals Ltd Derivados de benzimidazolil-metil urea como agonistas del receptor de alx
CN117447298A (zh) * 2023-08-29 2024-01-26 上海泰坦科技股份有限公司 一种卤代甲基二氟甲基苯的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793246B1 (fr) * 1999-05-03 2001-06-29 Adir Nouveaux derives de 1-aza-2-alkyl-6-aryl-cycloalcanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1268434A1 (de) * 2000-04-03 2003-01-02 Bristol-Myers Squibb Pharma Company Zyklische lactame als a-beta proteinproduktionsinhibitoren
ZA200507806B (en) * 2003-03-24 2007-03-28 Actimis Pharmaceuticals Inc 2-phenoxy- and 2-enysulfomamide derivatives with CCR3 antagonistic acitivity for the treatment of asthma and other inflammatory or immunolgical disorders
EP1680406A1 (de) * 2003-10-29 2006-07-19 Elan Pharmaceuticals, Inc. N-substituierte benzolsulfonamide
RU2378258C2 (ru) * 2004-07-13 2010-01-10 Ф. Хоффманн-Ля Рош Аг Производные сульфонамида

Also Published As

Publication number Publication date
CA2619223A1 (en) 2007-02-22
AR055370A1 (es) 2007-08-22
BRPI0614566A2 (pt) 2009-08-04
KR101020397B1 (ko) 2011-03-08
CN101238106A (zh) 2008-08-06
IL189026A0 (en) 2008-08-07
CN101238106B (zh) 2011-02-16
WO2007020190A1 (en) 2007-02-22
ES2355581T3 (es) 2011-03-29
KR20080027936A (ko) 2008-03-28
DE602006019103D1 (de) 2011-02-03
ZA200800930B (en) 2009-02-25
JP2009504600A (ja) 2009-02-05
US7501406B2 (en) 2009-03-10
US20070037789A1 (en) 2007-02-15
RU2419611C2 (ru) 2011-05-27
EP1915345B1 (de) 2010-12-22
EP1915345A1 (de) 2008-04-30
MX2008001833A (es) 2008-04-09
TWI325421B (en) 2010-06-01
NO20080498L (no) 2008-03-07
TW200734308A (en) 2007-09-16
AU2006281493A1 (en) 2007-02-22
JP4885958B2 (ja) 2012-02-29
RU2008103452A (ru) 2009-09-20

Similar Documents

Publication Publication Date Title
NL301109I1 (nl) Cabotegravir
LTC2004635I2 (lt) Pakeistieji enaminokarbonilo junginiai
CY2013047I1 (el) Ενωσεις διαρυλυδαντοϊνης
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
DE602006020996D1 (de) Hreren eingängen
ATE408603T1 (de) Pyrazolylcarboxanilide
DK2035394T3 (da) 2-pyrazincarboxamidderivater
ATE510823T1 (de) Fungizide pyridinyloxysubstituierte phenylamidinderivate
DK2086968T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE549324T1 (de) Tetrahydrobenzoxazine
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da) Tiglien-3-onderivater
DE112006002964A5 (de) Zweirichtungsreflektanzverteilungsmessgerät
DE502005005839D1 (de) Feldgeerät
DE602006014973D1 (de) Neuartige cercosporamidderivate
EP1867636A4 (de) Pyridylmethylsulfonderivat
DE102005052834B8 (de) Punktschweißklebverbindung
EP1935879A4 (de) Substituiertes cycloalkenderivat
ATE485368T1 (de) Hiv - impfung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1915345

Country of ref document: EP